Unbiased News Awaits.
Get Started
SubscribeLogin
Israel-Hamas Conflict
Eid
World Cup
Cristiano Ronaldo
Soccer
Elon Musk
Donald Trump
South America
Social Media
Artificial Intelligence
Drones
Latin America
Tesla
Arcutis Biotherapeutics image

News from Arcutis Biotherapeutics

Information about Arcutis Biotherapeutics

Where is Arcutis Biotherapeutics located?Arcutis Biotherapeutics's Website

Media Bias Ratings

Do you diasgree?
Edit bias
Learn more about Media Bias Ratings.

Factuality

Learn more about  Factuality Ratings

Reveal Factuality Ratings by upgrading to a Premium account.

Tap Upgrade to explore subscription options to meet all your reading needs.

Ownership

Learn more about  Ownership categories

Reveal Ownership Data by upgrading to a Vantage account.

Tap Upgrade to explore subscription options to meet all your reading needs.

Top Arcutis Biotherapeutics News

Pacira BioSciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Pacira BioSciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

50% Center coverage: 4 sources
BRISBANE, Calif., June 05, 2025 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (Nasdaq: PCRX), the industry leader in the delivery of innovative, non-opioid pain therapies to transform the lives of patients, today announced the granting of inducement awards on June 3,…See the Story
Arcutis’ Roflumilast Becomes First FDA-Approved Treatment to Receive the NPF’s Seal of Recognition
Alexandria, VA · Alexandria

Arcutis’ Roflumilast Becomes First FDA-Approved Treatment to Receive the NPF’s Seal of Recognition

The National Psoriasis Foundation Seal of Recognition program has expanded to prescription drugs, making roflumilast the first to achieve the indication.See the Story
Arcutis to Present at the Goldman Sachs 46th Annual Global Healthcare Conference - Arcutis Biotherapeutics
Westlake Village · Westlake Village

Arcutis to Present at the Goldman Sachs 46th Annual Global Healthcare Conference - Arcutis Biotherapeutics

WESTLAKE VILLAGE, Calif., May 29, 2025 (GLOBE NEWSWIRE) — Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT), a commercial-stage biopharmaceutical company focused on developing meaningful innovations in immuno-dermatology, today announced that Arcutis management will participate in the Goldman Sachs 46th Annual Global Healthcare Conference, taking place June 9-11, 2025. Details for the company’s participation are as follows: Fireside Chat Date: Tuesda…Read Article

Arcutis wins FDA nod for Zoryve foam for plaque psoriasis

100% Right coverage: 1 sources
Artificial Intelligence · United StatesSee the Story

New Guidance Aims to Improve Genital Psoriasis Treatment

New guidelines from the Genital Psoriasis Wellness Consortium highlight the significant impact of genital psoriasis on patients, emphasizing improved diagnosis and personalized treatment.Maryland · MarylandSee the Story

Single steroid-free psoriasis foam treats both scalp and body

A recent Phase 3 clinical trial demonstrated that a steroid-free topical foam, roflumilast (Zoryve), significantly improved the signs and symptoms of psoriasis on both the scalp and body. The foam treatment, which targets inflammation and reduces itching, offers a unified approach to treating psoriasis, eliminating the need for separate prescriptions for different body areas. With promising results and minimal adverse events, roflumilast foam co…FDASee the Story

Arcutis Announces First Quarter 2025 Financial Results and Provides Business Update - Arcutis Biotherapeutics

Q1 2025 net product revenue for ZORYVE® (roflumilast) was $63.8 million, a 196% increase compared to Q1 of 2024, and a 2% decrease compared to Q4 of 2024, due to typical first-quarter deductible resets and insurance changes, and excluding the non-recurring reduction in reserves for product return of $4.1 million reported in Q4 2024 Continued demand growth for ZORYVE of 10%, solidifying its position as most prescribed branded non-steroidal topica…Westlake Village · Westlake VillageRead Article

Xilio Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - Xilio Therapeutics (NASDAQ:XLO)

100% Center coverage: 1 sources
WALTHAM, Mass., May 02, 2025 (GLOBE NEWSWIRE) -- Xilio Therapeutics, Inc. (NASDAQ:XLO), a clinical-stage biotechnology company discovering and developing tumor-activated immuno-oncology therapies for people living with cancer, today announced that, effective May 1, 2025, the company granted a non-qualified stock option to purchase 5,000 shares of its common stock to one new employee under Xilio Therapeutics' 2022 Inducement Stock Incentive Plan.…Finance · WalthamSee the Story

Kinaxis Inc. to Host First Quarter 2025 Financial Results Conference Call on May 8, 2025

58% Center coverage: 81 sources
OTTAWA, Ontario--(BUSINESS WIRE)--Apr 16, 2025-Marriott InternationalSee the Story

Arcutis Appoints Latha Vairavan as Chief Financial Officer

Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT), a commercial-stage biopharmaceutical company focused on developing meaningful innovations in immunodermatology, today announced that David Topper, Arcutis’ chief financial officer (CFO) is retiring from the Company and Latha Vairavan, currently vice president and controller, will assume the role of CFO and join the executive team as part of a planned succession. Mr. Topper will continue to serve as C…Westlake Village · Westlake VillageSee the Story

Arcutis and Padagis Agree to Stay Patent Lawsuit - Arcutis Biotherapeutics

WESTLAKE VILLAGE, Calif., April 02, 2025 (GLOBE NEWSWIRE) — Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT), a commercial-stage biopharmaceutical company focused on developing meaningful innovations in immuno-dermatology, is pleased to announce that Padagis Israel Pharmaceuticals Ltd., Padagis US LLC, and Padagis LLC (Padagis) have requested a stay to the ongoing patent litigation between Padagis and the Company, and the Company has agreed to enter…Westlake Village · Westlake VillageRead Article

Breaking News Topics Related to Arcutis Biotherapeutics

Westlake Village

Westlake Village

Los Angeles County

Los Angeles County

California, United States

California, United States

United States

United States

News
For You
SearchBlindspotLocal